Covexin 10

Country: New Zealand

Language: English

Source: Ministry for Primary Industries

Active ingredient:

clostridium haemolyticum toxoid/cells; clostridium chauvoei toxoid/cells; clostridium perfringens type c toxoid; clostridium perfringens type b toxoid/cells; clostridium tetani toxoid; clostridium perfringens type d toxoid; clostridium novyi type b toxoid/cells; clostridium perfringens type a toxoid; clostridium septicum toxoid; clostridium sordellii toxoid

Available from:

Schering-Plough Animal Health Limited

INN (International Name):

clostridium perfringens type c toxoid, clostridium perfringens type d toxoid, clostridium perfringens type a toxoid, clostridium

Composition:

clostridium haemolyticum toxoid/cells 0 vaccine; clostridium chauvoei toxoid/cells 0 vaccine; clostridium perfringens type c toxoid 0 vaccine; clostridium perfringens type b toxoid/cells 0 vaccine; clostridium tetani toxoid 0 vaccine; clostridium perfringens type d toxoid 0 vaccine; clostridium novyi type b toxoid/cells 0 vaccine; clostridium perfringens type a toxoid 0 vaccine; clostridium septicum toxoid 0 vaccine; clostridium sordellii toxoid 0 vaccine

Therapeutic area:

Vaccine

Authorization status:

ACVM Registered

Authorization date:

2002-09-26

Summary of Product characteristics

COVEXIN 10
100 mL / 500 mL – Leaflet, Carton and Label
A009028
Page 1 of 8
COVEXIN 10
01-Sep-23
Leaflet
WARNING
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
COVEXIN
® 10
10-in-1 Clostridial Vaccine
100 ML (50 DOSES*)
500 ML (250 DOSES*)
READ ENTIRE LEAFLET BEFORE USE.
COVEXIN 10 contains toxoids of _Clostridium perfringens_ (types A, B,
C and D), _C. novyi _(type B),
_C. septicum, C. tetani,_ _C. sordellii,_ and _C. haemolyticum_ and
whole cell culture of _C. chauvoei_.
COVEXIN 10 also contains potash alum adjuvant and 0.015% w/v
thiomersal.
INDICATIONS
For the active immunisation of sheep and cattle from 2 weeks of age
against diseases caused by
_Clostridium perfringens_ type A (enterotoxaemia, gas gangrene, sudden
death syndrome), _C. _
_perfringens_ type B (lamb dysentery, enterotoxaemia), _C.
perfringens_ type C (enterotoxaemia,
struck), _C. perfringens_ type D (enterotoxaemia, pulpy kidney), C.
_chauvoei_ (black leg, black
quarter, post parturient gangrene), _C._ _novyi _type B (black
disease, infectious necrotic hepatitis), _C_.
_septicum_ (malignant oedema, braxy), _C._ _tetani_ (tetanus), _C.
sordellii_ (sudden death syndrome),
and _C. haemolyticum_ (red water disease).
Full protection develops within 14 days of administration of the
second dose. Duration of immunity
is approximately 12 months from initial vaccination. Studies show that
revaccination every 12
months is adequate to generate and maintain immunity. Where high
levels of challenge are
anticipated, more frequent booster vaccination may need to be
considered.
EQUIPMENT_ _
•
Use sharp needles.
•
Change needles frequently (every 12 to 20 animals).
•
Needles and vaccinator guns should be sterile before starting. Needles
can be sterilised by
boiling for 10 minutes and storing in methylated spirits.
ASSEMBLY OF VAXIPAK
® AND DRAW-OFF SET_ _
1. Attach end of draw-off tube to the vaccinator gun.
2. Pierce centre of rubber stopper of Vaxipak with draw-off needle,
ensuring that plastic overcap
snaps into position on the Vaxipak cap.